Protocol

Postmarketing commitment safety study of HZ/su to evaluate pregnancy exposures and outcomes in immunodeficient or immunosuppressed women between 18 and 49 years of age

March 31, 2023
Authors:

Harvard Pilgrim Health Care Institute, CVS Health, Carelon Research, Optum Epidemiology, GlaxoSmithKline

Capability:
Pregnancy & Mother-Infant Linked Studies
Multi-Site Methods & Coordination
Expertise:
Regulatory Research & Support
RWE Research & Consulting
Home
Publications
Postmarketing commitment safety study of HZ/su to evaluate pregnancy exposures and outcomes in immunodeficient or immunosuppressed women between 18 and 49 years of age
...
View the public protocol
CONTACT US

© Real-World Evidence Practice. All rights reserved.

Harvard Pilgrim Health Care Institute Department of Population Medicine
Privacy Policy